CN110772553A - 复方蛇脂软膏的制备方法 - Google Patents
复方蛇脂软膏的制备方法 Download PDFInfo
- Publication number
- CN110772553A CN110772553A CN201911081999.6A CN201911081999A CN110772553A CN 110772553 A CN110772553 A CN 110772553A CN 201911081999 A CN201911081999 A CN 201911081999A CN 110772553 A CN110772553 A CN 110772553A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- ginseng
- stirring
- percolate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开一种复方蛇脂软膏的制备方法,包括重量份原料为:蛇脂,珍珠粉,维生素A,维生素D3,维生素E,人参,冰片,硼酸;包括重量份辅料为:硬脂酸,三乙醇胺,甘油,羟苯乙酯,香精;其制备方法主要将人参经过多道工序提取渗漉液,精制而成的人参膏与其他药物可以更好的融合,结合水相原辅料,油相原辅料,经乳化制成膏剂。采用该制备方法所得膏剂性质稳定,适合大多数人的体质,对所针对的症状的治愈率高达98%以上。
Description
技术领域
本发明属于药膏制备技术领域,尤其涉及复方蛇脂软膏的制备方法。
背景技术
蛇脂软膏是一种可以治疗皮肤疾病的药物,包括治疗癬症、湿疹、皮炎、皮肤皱裂、干燥等症。事实上,蛇油本身就具备一定的治疗作用,现阶段市面上的所制备的蛇脂软膏,如公开号为CN1660251A,一种中药抗真菌软膏及其制备方法,该技术方案中虽然也将药物制成膏剂,但其制备方法则是简单的浸渍液与其他物料的融合,这种制备方式实际上只利用了药物本身的药性叠加,如蛇油具备治疗皮肤干燥的效果一样,无法完全融合药性,虽然无毒无副作用,但药效所发挥的作用或许只能达到30%-40%,治愈率或许达不到70%。
发明内容
鉴于上述现有技术的不足,本发明的目的在于提供一种药效稳定,复方蛇脂软膏的制备方法。
为解决上述技术问题,本发明所采用的技术方案是:
本发明为复方蛇脂软膏的制备方法,包括重量份原料为:蛇脂40-42份,珍珠粉1-3份,维生素A0.001-0.01份,维生素D30.03-0.05份,维生素E0.3-0.5份,人参0.6-0.8份,冰片1-2份,硼酸0.6-0.8份;包括重量份辅料为:硬脂酸30-34份,三乙醇胺6-8份,甘油18-20份,羟苯乙酯0.2-0.5份,香精2-5份;
制备方法包括以下步骤:
(1)按比例取人参制粉,过24目筛为人参粗粉,加浓度为70%的乙醇在渗漉罐内浸渍,提取渗漉液;
(2)渗漉液采用开口加热方式浓缩,使药液蒸发乙醇浓缩至适量,相对密度为1.30-1.32(80℃)时,关闭加热器,将浸膏趁热收集至洁净、消毒的容器内,密闭并贴上标识;
(3)将浸膏置于真空干燥箱中,控制温度80℃,真空度-0.2MPa,干燥时间为6h,干燥完毕则关闭加热开关,打开开气阀,逐渐放入空气,而后取出干膏,放入洁净、消毒的不锈钢容器中,密闭并贴上标识;
(4)将人参干膏置于摇摆式多功能粉碎机粉碎成细粉,装入洁净周转桶中,贴好标识;
(5)按比例取硬脂酸与蛇脂投入油相锅内,加热至120℃使其溶化,停止加热并冷却至85℃,加入冰片,搅拌均匀后,冷却至75-82℃以下备用;
(6)按比例取甘油、三乙醇胺投入水相锅内,加入195份纯化水,加热搅拌,至100℃时加入珍珠粉,人参干膏粉,羟苯乙酯,硼酸,搅拌均匀后冷却至80℃备用;
(7)将油相锅与水相锅内的混合液料在乳化锅中进行乳化,维持乳化锅内温度为80±3℃,刮板搅拌器速度为50-70r/min,在搅拌过程中按比例加入维生素A,维生素D3,维生素E的混合溶液;而后开启冷却水,启动均质器进行均质乳化,连续搅拌10分钟,关闭均质器,当温度冷却至55℃时按比例加入香精,刮板搅拌器继续搅拌冷却至室温,将制得的膏体转移至洁净容器中,等待灌装即可。
本发明的70%乙醇用量为人参粗粉的8倍量,渗漉过程为:先加入2倍量的70%乙醇与人参粗粉搅拌均匀,加盖密闭湿润24h,装入渗漉罐中,装入渗漉罐时应均匀,松紧一致,排除药材间隙中的空气,使药材充分膨胀,再加入1.5倍量70%乙醇,溶剂需高于药面,加盖密闭浸渍24h,初漉液流出速度控制在2ml/min,收集85%的初漉液另器保存;将剩余的70%乙醇逐步加至渗漉罐中,继续保持溶剂高于药面,收集续漉液,续漉液收集速度控制在3ml/min,收集完毕后与初漉液合并。
本发明的复方蛇脂软膏的制备方法,在制备过程中往乳化锅内加入油相液料时需在加料口处设置100目不锈钢过滤网过滤。
本发明主要将人参经过多道工序提取渗漉液,精制而成的人参膏作为基质与其他药物可以更好的融合,结合水相原辅料,油相原辅料,经乳化制成膏剂。采用该制备方法所得膏剂性质稳定,适合大多数人的体质,具有养阴润燥愈裂,对阴津不足,肌肤失养所致的手足皱裂,皮肤干燥有很好的疗效,对所针对的症状的治愈率高达98%以上。
附图说明:
图1为本发明的工艺流程图。
具体实施方式:
实施例1:
本发明为复方蛇脂软膏的制备方法,包括重量份原料为:蛇脂40份,珍珠粉3份,维生素A0.01份,维生素D30.05份,维生素E0.3份,人参0.8份,冰片2份,硼酸0.6份;包括重量份辅料为:硬脂酸30份,三乙醇胺6份,甘油20份,羟苯乙酯0.2份,香精2份。
实施例2:
本发明为复方蛇脂软膏的制备方法,包括重量份原料为:蛇脂42份,珍珠粉1份,维生素A0.001份,维生素D30.03份,维生素E0.5份,人参0.6份,冰片1份,硼酸0.8份;包括重量份辅料为:硬脂酸32份,三乙醇胺8份,甘油18份,羟苯乙酯0.5份,香精5份。
实施例3:
本发明为复方蛇脂软膏的制备方法,包括重量份原料为:蛇脂41份,珍珠粉2.5份,维生素A0.005份,维生素D30.045份,维生素E0.4份,人参0.7份,冰片1.5份,硼酸0.7份;包括重量份辅料为:硬脂酸34份,三乙醇胺7份,甘油19份,羟苯乙酯0.25份,香精4.5份。
实施例4:
本发明为复方蛇脂软膏的制备方法,包括重量份原料为:蛇脂41.4份,珍珠粉1.36份,维生素A0.0087份,维生素D30.0496份,维生素E0.45份,人参0.76份,冰片1.8份,硼酸0.6份;包括重量份辅料为:硬脂酸31.5份,三乙醇胺6.5份,甘油18.5份,羟苯乙酯0.28份,香精3.2份。
实施例5:
本发明为复方蛇脂软膏的制备方法,包括重量份原料为:蛇脂42份,珍珠粉1.5份,维生素A0.003份,维生素D30.0375份,维生素E0.3份,人参0.66份,冰片1.2份,硼酸0.6份;包括重量份辅料为:硬脂酸33份,三乙醇胺7.5份,甘油19.5份,羟苯乙酯0.45份,香精2.4份。
参考图1,上述实施例均通过以下制备方法制备:
(1)取人参药材和95%医用乙醇,将人参置于高效粉碎机粉碎成粗粉,过24目筛,装入洁净的周转桶中,贴好标识;将95%乙醇配置成浓度为70%的乙醇,配置量为人参粗粉的8倍量;按比例称量取人参粗粉,与70%乙醇进行渗漉,提取渗漉液;
渗漉过程为:先加入2倍量的70%乙醇与人参粗粉搅拌均匀,加盖密闭湿润24h,装入渗漉罐中,装入渗漉罐时应均匀,松紧一致,排除药材间隙中的空气,使药材充分膨胀,再加入1.5倍量70%乙醇,溶剂需高于药面,加盖密闭浸渍24h,初漉液流出速度控制在2ml/min,收集85%的初漉液另器保存;将剩余的70%乙醇逐步加至渗漉罐中,继续保持溶剂高于药面,收集续漉液,续漉液收集速度控制在3ml/min,收集完毕后与初漉液合并。
(2)合并的渗漉液采用开口加热方式浓缩,使药液蒸发乙醇浓缩至适量,相对密度为1.30-1.32(80℃)时,关闭加热器,将浸膏趁热收集至洁净、消毒的容器内,密闭并贴上标识;
(3)将浸膏置于真空干燥箱中,开干燥箱电源及真空泵开关,干燥箱开始升温,控制温度80℃,真空度-0.2MPa,干燥时间为6h,干燥完毕则关闭加热开关,打开开气阀,逐渐放入空气使真空表指针慢慢归零,而后取出干膏,放入洁净、消毒的不锈钢容器中,密闭并贴上标识;
(4)将人参干膏置于摇摆式多功能粉碎机粉碎成细粉,装入洁净周转桶中,贴好标识;
(5)按比例取硬脂酸与蛇脂投入油相锅内,加热至120℃使其溶化,停止加热并冷却至85℃,加入冰片,搅拌均匀后,冷却至75-82℃以下备用;
(6)按比例取甘油、三乙醇胺投入水相锅内,加入195份纯化水,加热搅拌,至100℃时加入珍珠粉,人参干膏粉,羟苯乙酯,硼酸,搅拌均匀后冷却至80℃备用;
(7)将油相锅与水相锅内的混合液料在乳化锅中进行乳化,关闭乳化锅上的所有阀门,打开真空气动阀门,启动真空泵按钮,在真空度达到-0.08mPa以上,依次开启水相、油相贮罐管道上的手动阀门进行吸料,在吸油相料液时需在进料口加100目不锈钢过滤网过滤。吸完料后关闭手动阀门及真空按钮,维持乳化锅内温度为80±3℃,启动刮板搅拌器速度为50-70r/min,在搅拌过程中按比例加入维生素A,维生素D3,维生素E的混合溶液(三种维生素先混合用温水搅拌溶解后投料),开启冷却水,启动均质器进行均质乳化,连续搅拌10分钟,关闭均质器,当温度冷却至55℃时按比例加入香精,刮板搅拌器继续搅拌冷却,在冷却过程中刮板速度随温度降低而逐渐降低,待冷却至室温即得膏体,将制得的膏体转移至洁净容器中,等待灌装即可。
膏剂在灌装封尾前后进行取样检验,灌装封尾后装大小盒,而后装箱便可形成成品入库。
本发明主要以人参的浸渍液做人参膏形成主要基质,人参的浸出液可被皮肤缓慢吸收且无不良刺激,能扩张皮肤毛细血管,促进皮肤血液循环,调节皮肤的水油平衡,并且能抑制黑色素的还原性。采用人参复合浸渍液所形成的人参膏充分提取了人参的精华,配合水相原辅料:纯化水、甘油、三乙醇胺、羟苯乙酯、硼酸;配合油相原辅料:蛇脂、硬脂酸、冰片。形成膏剂,水相物料,油相物料的完美融合,所制得的软膏性质稳定,经稳定性试验考察,结果符合膏剂稳定性考察要求。
本发明的复方蛇脂软膏,作为临床试用,挑选10个包括癣菌感染、孢子丝菌感染、表皮癣菌、手指冻疮、足跟开裂、肤色暗黄无光泽、角质及脸部斑点等皮肤患者,对这些患者进行为期一周的膏剂外用,具体为早晚洁肤后各用一次,严重者中午加多一次,一周后,10个患者中有9个基本症愈,剩余1个属皮肤暗黄无光患者,该患者脸部光泽明显有所改善,但由于其体内营养不均衡,体质偏差等缘故,需长期使用,同时配合内服药物使机体平衡。
应当理解的是,本项发明的技术性范围并不局限于说明书上的内容,对本领域普通技术人员来说,可以根据上述说明加以改进或变换,所有这些改进和变换都应属于本发明所附权利要求的保护范围。
Claims (3)
1.复方蛇脂软膏的制备方法,其特征在于:包括重量份原料为:蛇脂40-42份,珍珠粉1-3份,维生素A0.001-0.01份,维生素D30.03-0.05份,维生素E0.3-0.5份,人参0.6-0.8份,冰片1-2份,硼酸0.6-0.8份;包括重量份辅料为:硬脂酸30-34份,三乙醇胺6-8份,甘油18-20份,羟苯乙酯0.2-0.5份,香精2-5份;
制备方法包括以下步骤:
(1)按比例取人参制粉,过24目筛为人参粗粉,加浓度为70%的乙醇在渗漉罐内浸渍,提取渗漉液;
(2)渗漉液采用开口加热方式浓缩,使药液蒸发乙醇浓缩至适量,相对密度为1.30-1.32(80℃)时,关闭加热器,将浸膏趁热收集至洁净、消毒的容器内,密闭并贴上标识;
(3)将浸膏置于真空干燥箱中,控制温度80℃,真空度-0.2MPa,干燥时间为6h,干燥完毕则关闭加热开关,打开开气阀,逐渐放入空气,而后取出干膏,放入洁净、消毒的不锈钢容器中,密闭并贴上标识;
(4)将人参干膏置于摇摆式多功能粉碎机粉碎成细粉,装入洁净周转桶中,贴好标识;
(5)按比例取硬脂酸与蛇脂投入油相锅内,加热至120℃使其溶化,停止加热并冷却至85℃,加入冰片,搅拌均匀后,冷却至75-82℃以下备用;
(6)按比例取甘油、三乙醇胺投入水相锅内,加入195份纯化水,加热搅拌,至100℃时加入珍珠粉,人参干膏粉,羟苯乙酯,硼酸,搅拌均匀后冷却至80℃备用;
(7)将油相锅与水相锅内的混合液料在乳化锅中进行乳化,维持乳化锅内温度为80±3℃,刮板搅拌器速度为50-70r/min,在搅拌过程中按比例加入维生素A,维生素D3,维生素E的混合溶液;而后开启冷却水,启动均质器进行均质乳化,连续搅拌10分钟,关闭均质器,当温度冷却至55℃时按比例加入香精,刮板搅拌器继续搅拌冷却至室温,将制得的膏体转移至洁净容器中,等待灌装即可。
2.根据权利要求1所述的复方蛇脂软膏的制备方法,其特征在于:所述70%乙醇用量为人参粗粉的8倍量,渗漉过程为:先加入2倍量的70%乙醇与人参粗粉搅拌均匀,加盖密闭湿润24h,装入渗漉罐中,装入渗漉罐时应均匀,松紧一致,排除药材间隙中的空气,使药材充分膨胀,再加入1.5倍量70%乙醇,溶剂需高于药面,加盖密闭浸渍24h,初漉液流出速度控制在2ml/min,收集85%的初漉液另器保存;将剩余的70%乙醇逐步加至渗漉罐中,继续保持溶剂高于药面,收集续漉液,续漉液收集速度控制在3ml/min,收集完毕后与初漉液合并。
3.根据权利要求1或2所述的复方蛇脂软膏的制备方法,其特征在于:往乳化锅内加入油相液料时需在加料口处设置100目不锈钢过滤网过滤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911081999.6A CN110772553A (zh) | 2019-11-07 | 2019-11-07 | 复方蛇脂软膏的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911081999.6A CN110772553A (zh) | 2019-11-07 | 2019-11-07 | 复方蛇脂软膏的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110772553A true CN110772553A (zh) | 2020-02-11 |
Family
ID=69389546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911081999.6A Pending CN110772553A (zh) | 2019-11-07 | 2019-11-07 | 复方蛇脂软膏的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110772553A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880627A (en) * | 1985-11-07 | 1989-11-14 | Tecma Laboratories | Skin therapeutic mixture containing eupatorium extract and formulations |
CN101444554A (zh) * | 2008-12-26 | 2009-06-03 | 漳州市健源堂生物工程有限公司 | 蛇脂软膏及其制备方法 |
-
2019
- 2019-11-07 CN CN201911081999.6A patent/CN110772553A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880627A (en) * | 1985-11-07 | 1989-11-14 | Tecma Laboratories | Skin therapeutic mixture containing eupatorium extract and formulations |
CN101444554A (zh) * | 2008-12-26 | 2009-06-03 | 漳州市健源堂生物工程有限公司 | 蛇脂软膏及其制备方法 |
Non-Patent Citations (2)
Title |
---|
徐怀德 主编: "《天然产物提取工艺学》", 30 June 2008, 北京:中国轻工业出版社 * |
马振友 等主编: "《新编中西皮肤药物手册》", 31 January 2019, 郑州:河南科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110051782A (zh) | 人参膏及其制备工艺 | |
CN102008411B (zh) | 一种护肤霜生产配方及其制备方法 | |
CN109123301A (zh) | 一种芦笋发酵固体饮料及其制备方法和应用 | |
CN103202470A (zh) | 一种辅助降血糖的保健食品及其制备方法 | |
CN102008632A (zh) | 治疗糖尿病的降糖茶 | |
WO2023108683A1 (zh) | 一种黄精酒 | |
CN102652564B (zh) | 一种补肾益气酱鸭的制备方法 | |
CN107260842A (zh) | 一种复方白芍半枝莲抗大肠癌口服液及其制备工艺 | |
CN103446279A (zh) | 一种降血脂制剂 | |
CN110772553A (zh) | 复方蛇脂软膏的制备方法 | |
CN113057315A (zh) | 一种辅助降血糖的保健食品及其制备方法 | |
WO2004029192A2 (en) | Producing method of tien hsien liquid | |
CN111840411A (zh) | 一种降脂茶的制备方法 | |
CN106729498A (zh) | 一种放化疗后食用的蛋白粉及其制备方法 | |
CN101099814B (zh) | 一种延缓男性衰老的药物组合物 | |
CN106578959B (zh) | 一种适用于糖尿病人的食品及其生产工艺 | |
CN107637741A (zh) | 一种蒲公英亚麻籽饮料及其制备方法 | |
KR101778142B1 (ko) | 항당뇨 활성이 강화된 장생도라지 복합조성물 및 제조방법 | |
CN107260817A (zh) | 一种降血压口服液及其制备工艺 | |
CN104173712A (zh) | 一种术后安神益气的中药组合物及其制备方法 | |
CN109090403A (zh) | 一种含有荔枝核提取物的保健饮料及其加工方法 | |
CN107890519A (zh) | 一种铁皮石斛软胶囊及其制备方法 | |
CN103463234A (zh) | 一种具有调节血脂功能的保健食品 | |
CN107375468A (zh) | 一种复方黄芪白术抗肺癌口服液及其制备工艺 | |
CN110862899A (zh) | 葛根黄精醋及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200211 |